$31.48
At close: Mar 26, 7:59 PM EDT
$31.35
-0.13-0.42%
After Hours: 7:59 PM EDT
Comments
Loading...
Latest Moderna Stock News | NASDAQ:MRNA | Benzinga
Get the latest news on Moderna stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Moderna performance
Categories: All
Wednesday, March 26, 2025
Sunday, March 23, 2025
Friday, March 21, 2025
Thursday, March 20, 2025
Thursday, March 13, 2025
Tuesday, March 11, 2025
Monday, March 10, 2025
Sunday, March 09, 2025
Friday, March 07, 2025
Wednesday, March 05, 2025
Tuesday, March 04, 2025
Monday, March 03, 2025
Friday, February 28, 2025
Thursday, February 27, 2025
Wednesday, February 26, 2025
Monday, February 24, 2025
Friday, February 21, 2025
Thursday, February 20, 2025
Wednesday, February 19, 2025
Tuesday, February 18, 2025
- Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday
- Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges
- RBC Capital Reiterates Sector Perform on Mode...
- This Moderna Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
- Barclays Downgrades Moderna to Equal-Weight, ...
Monday, February 17, 2025
Friday, February 14, 2025
- Moderna shares are trading higher after the c...
- Trump Order Halts Funding For School Covid Va...
- Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday?
- 10 Health Care Stocks With Whale Alerts In Today's Session
- Applied Materials, Informatica, Clearwater Paper And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- Moderna Struggles With Declining Q4 COVID Vaccine Sales, Stock Slides
- Moderna Reiterates 2025 Expected Revenue Of $...
- Moderna Q4 2024 GAAP EPS $(2.91) Misses $(2.6...
- Dow Jumps Over 300 Points Following Recent Inflation Data; Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone
- Palo Alto Networks, Moderna And 3 Stocks To Watch Heading Into Friday
- US Stocks Set For A Volatile Start: Analyst Dismisses Chances Of 20%+ S&P 500 Gain For Third Year In A Row, But Says 'Investors Should Be Optimistic'
- Earnings Scheduled For February 14, 2025